“…In fact, the majority of in vitro studies making use of different sources confirm that in the therapeutically relevant dose range of a few Gy, even if applied in a single pulse of only few nanoseconds duration, non-linear radiobiological effects due to simultaneous multiple damages in cells and, thus, below any timescale of repair mechanisms, are unlikely to arise [30][31][32][33][34][35]. Only two relevant exceptions exist: Achayra et al [36], who reported a decrease in genetic damage measured as micronucleus formation after a single pulse of electrons but not after multiple pulses (10 6 to 10 8 Gy/s), hypothesising more efficient radical recombination; Schmid et al [37], who found a slight decrease in effectiveness at causing (some types of) chromosome aberrations after nanopulsed protons (conventionally accelerated). Of fundamental importance to gain insights into laser-driven particle biological effectiveness is, of course, in vivo work.…”
A: Accelerated proton beams have become increasingly common for treating cancer. The need for cost and size reduction of particle accelerating machines has led to the pioneering investigation of optical ion acceleration techniques based on laser-plasma interactions as a possible alternative. Laser-matter interaction can produce extremely pulsed particle bursts of ultra-high dose rates (≥ 10 9 Gy/s), largely exceeding those currently used in conventional proton therapy. Since biological effects of ionizing radiation are strongly affected by the spatio-temporal distribution of DNA-damaging events, the unprecedented physical features of such beams may modify cellular and tissue radiosensitivity to unexplored extents. Hence, clinical applications of laser-generated particles need thorough assessment of their radiobiological effectiveness. To date, the majority of studies have either used rodent cell lines or have focussed on cancer cell killing being local tumour control the main objective of radiotherapy. Conversely, very little data exist on sub-lethal cellular effects, of relevance to normal tissue integrity and secondary cancers, such as premature cellular senescence. Here, we discuss ultra-high dose rate radiobiology and present preliminary 1Corresponding author.
“…In fact, the majority of in vitro studies making use of different sources confirm that in the therapeutically relevant dose range of a few Gy, even if applied in a single pulse of only few nanoseconds duration, non-linear radiobiological effects due to simultaneous multiple damages in cells and, thus, below any timescale of repair mechanisms, are unlikely to arise [30][31][32][33][34][35]. Only two relevant exceptions exist: Achayra et al [36], who reported a decrease in genetic damage measured as micronucleus formation after a single pulse of electrons but not after multiple pulses (10 6 to 10 8 Gy/s), hypothesising more efficient radical recombination; Schmid et al [37], who found a slight decrease in effectiveness at causing (some types of) chromosome aberrations after nanopulsed protons (conventionally accelerated). Of fundamental importance to gain insights into laser-driven particle biological effectiveness is, of course, in vivo work.…”
A: Accelerated proton beams have become increasingly common for treating cancer. The need for cost and size reduction of particle accelerating machines has led to the pioneering investigation of optical ion acceleration techniques based on laser-plasma interactions as a possible alternative. Laser-matter interaction can produce extremely pulsed particle bursts of ultra-high dose rates (≥ 10 9 Gy/s), largely exceeding those currently used in conventional proton therapy. Since biological effects of ionizing radiation are strongly affected by the spatio-temporal distribution of DNA-damaging events, the unprecedented physical features of such beams may modify cellular and tissue radiosensitivity to unexplored extents. Hence, clinical applications of laser-generated particles need thorough assessment of their radiobiological effectiveness. To date, the majority of studies have either used rodent cell lines or have focussed on cancer cell killing being local tumour control the main objective of radiotherapy. Conversely, very little data exist on sub-lethal cellular effects, of relevance to normal tissue integrity and secondary cancers, such as premature cellular senescence. Here, we discuss ultra-high dose rate radiobiology and present preliminary 1Corresponding author.
“…These data are of high relevance for clinical use of laser-accelerated proton beams. Previous experiments on monolayer and 3D tissue cultures (in vitro) did not provide evidence for significantly altered radiobiological effectiveness in terms of cytogenetic damage or DNA repair (8)(9)(10)(11)(12). The RBE values determined for pulsed and continuous irradiation modes were always comparable to the RBE of 1.1, which is achieved by conventional proton therapy (20).…”
Section: Discussionmentioning
confidence: 69%
“…However, based on our previous in vitro experiments (8)(9)(10)(11)(12) we do not expect a relevant difference between pulsed and conventional proton irradiation.…”
Section: The Effects Of Ultra-high Dose Rate Protons On Tumors In Micementioning
confidence: 80%
“…With respect to these endpoints no indication for a significantly altered efficiency of pulsed protons compared to a continuous irradiation was observed (8)(9)(10)(11). Further biological experiments were performed using a human skin tissue model to account for the 3D geometry and the cell interaction, again without statistically significant changes in RBE according to dose rate (12).…”
“…Very little is known as to the possible influence that very high dose rates or the pulsed time-structure in dose delivery may have on such late effects in the case of laser-driven charged particle beams. For example, Schmid et al [27] reported that 20 MeV protons in pulsed mode were slightly less effective at inducing CA in human-hamster hybrid cells as compared to this beam being delivered in conventional continuous fashion. However, no information was given on the complexity spectrum of such CAs as the latter were scored only with basic solid staining rather than by FISH.…”
The use of charged particles significantly reduces the dose absorbed by normal cells due to the inverse
dose-depth deposition profile. This is the physical pillar justifying hadrontherapy as the eligible treatment for deepseated
tumours. However, a non-negligible amount of radiation is nevertheless absorbed in correspondence with the
plateau region of the Bragg curve, which may result in the induction of sub-lethal effects. Very little experimental
data exist on the induction of such effects. Moreover, reliable follow-up data on such adverse effects in
hadrontherapy patients are limited since this type of treatment has been adopted relatively recently. A fortiori, the
dependence of sub-lethal effects on unprecedented factors, such as the exceedingly high dose rates and/or the pulsed
nature of beams originated by laser interaction with target materials, is unknown. This warrants investigation prior to
a therapeutic use of such beams
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.